Invesco Biotechnology & Genome ETF
PBE
PBE
94 hedge funds and large institutions have $70.3M invested in Invesco Biotechnology & Genome ETF in 2021 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 16 increasing their positions, 22 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
27% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 22
Holders
94
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.19M | |
| 2 | +$885K | |
| 3 | +$598K | |
| 4 |
Stifel Financial
St. Louis,
Missouri
|
+$525K |
| 5 |
LPL Financial
San Diego,
California
|
+$260K |
Top Sellers
| 1 | -$1.97M | |
| 2 | -$405K | |
| 3 | -$306K | |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
-$288K |
| 5 |
GT
Glenmede Trust
Philadelphia,
Pennsylvania
|
-$98.8K |